Examkin

Question

Difficulty: MediumInfectious Diseases

A medical team is reviewing the chart of an inpatient being treated for a severe right-sided soft tissue infection. The patient, who has a history of well-controlled type 2 diabetes mellitus, presented two days ago with rigors, marked localized erythema, and a temperature of 39.0 C (102.2 F). Upon admission, blood cultures were drawn, and empiric intravenous vancomycin and piperacillin-tazobactam were initiated. Today, the patient is clinically stable and afebrile. The microbiology laboratory reports that both sets of admission blood cultures are growing Staphylococcus aureus. Susceptibility testing indicates the isolate is sensitive to oxacillin, cefazolin, and clindamycin, but resistant to penicillin and ampicillin. Which of the following is the most appropriate next step in the pharmacologic management of this patient?

  1. Discontinue the current regimen and initiate intravenous cefazolinAnswer
  2. B
    Continue intravenous vancomycin and piperacillin-tazobactam
  3. C
    Discontinue piperacillin-tazobactam and continue intravenous vancomycin
  4. D
    Discontinue the current regimen and initiate intravenous daptomycin
  5. E
    Discontinue the current regimen and initiate oral clindamycin

Answer

Discontinue the current regimen and initiate intravenous cefazolin.
The correct action is to discontinue the broad-spectrum empiric regimen and initiate intravenous cefazolin. The patient has confirmed methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia, as evidenced by the isolate's sensitivity to oxacillin. For severe deep-tissue infections complicated by MSSA bacteremia, targeted therapy with an anti-staphylococcal beta-lactam (such as cefazolin, nafcillin, or oxacillin) is the gold standard. These agents are significantly more efficacious than vancomycin, demonstrating faster bacterial clearance and improved clinical outcomes. De-escalating from vancomycin and piperacillin-tazobactam to cefazolin perfectly aligns with core antimicrobial stewardship principles.

Step-by-Step Solution

1
Interpret the blood culture and susceptibility results.
The organism is Staphylococcus aureus that is sensitive to oxacillin, which definitively identifies it as methicillin-susceptible Staphylococcus aureus (MSSA).
Oxacillin susceptibility is the laboratory surrogate used to distinguish MSSA from methicillin-resistant S. aureus (MRSA).
2
Determine the optimal antibiotic class for MSSA bacteremia.
Anti-staphylococcal beta-lactams (such as cefazolin, nafcillin, or oxacillin) are the preferred agents.
Beta-lactams demonstrate superior bactericidal activity, faster bloodstream clearance, and lower mortality rates compared to vancomycin for MSSA infections.
3
Apply principles of antimicrobial stewardship.
The broad-spectrum empiric regimen (vancomycin and piperacillin-tazobactam) should be discontinued.
De-escalating to a targeted, narrow-spectrum agent prevents the development of antimicrobial resistance, minimizes collateral damage to the microbiome, and reduces drug toxicity.

Key Concept

Definitive management of methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia requires de-escalation to an intravenous anti-staphylococcal beta-lactam, which is superior to vancomycin.
Rate this question

Topics

Infectious Diseases

More questions from this topic